Ketamine Administration for Postoperative Pain Management in Patients Undergoing Knee Arthroplasty

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Knee ArthroplastyPostoperative PainPain ManagementAnalgesiaOpioid UseKetamine
Interventions
DRUG

Ketamine

Ketamine administered intravenously at 0.15 mg/kg/h via PCA with 1 mg boluses, 5-minute lockout, maximum 500 mg per 24 hours after knee arthroplasty.

DRUG

Standard Analgesia

Standard analgesia includes ketoprofen 100 mg twice daily and paracetamol 1000 mg every 8 hours for 24 hours after knee arthroplasty; morphine 10 mg IM as needed for rescue therapy.

Trial Locations (1)

105203

RECRUITING

Pirogov National Medical and Surgical Center, Moscow

All Listed Sponsors
lead

State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia

OTHER

NCT07059429 - Ketamine Administration for Postoperative Pain Management in Patients Undergoing Knee Arthroplasty | Biotech Hunter | Biotech Hunter